FCN3 and amyotrophic lateral sclerosis: Increased levels of C5a have been described in plasma as well as in the leukocytes of the peripheral blood of patients with ALS (28), and a significant upregulation of ficolin-3 which increase the potential of LP complement activation also been reported (54).